Citation Impact
Citing Papers
Preferential induction of apoptosis for primary human leukemic stem cells
2002
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
2008
An Overview of Cyclophosphamide and Ifosfamide Pharmacology
1997
Hallmarks of Cancer: The Next Generation
2011 Standout
Triple-Negative Breast Cancer
2010 Standout
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
2009
Cancer Stem Cells
2006
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
The Treatment of Multiple Myeloma
1994
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
Ribosome-inactivating proteins from plants
1993
Applying the principles of stem-cell biology to cancer
2003
The origin of the cancer stem cell: current controversies and new insights
2005
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells
2003 Nature
Cancer Metastasis: Building a Framework
2006 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Standout
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Ex vivo manipulation of hematopoietic stem and progenitor cells
2000
The Epigenomics of Cancer
2007 Standout
Therapeutic implications of cancer stem cells
2003
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
1992
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy
1995
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
2006
OPTIONS FOR THERAPY IN CHRONIC MYELOID LEUKAEMIA
1995
Hematopoietic Stem-Cell Transplantation
2006 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Mechanisms controlling pathogenesis and survival of leukemic stem cells
2004
Mechanisms of Disease: cancer stem cells—targeting the evil twin
2008
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
1997 Standout
Stem Cells and Cancer
2004 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Cancer stem cells: lessons from leukemia
2005
Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity
2004
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
Clonal evolution in cancer
2012 StandoutNature
Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML
2017
TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents
2006 StandoutNobel
Identification of human brain tumour initiating cells
2004 StandoutNature
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.
1993
Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo
2014
Chronic Myeloid Leukemia
1999
National estimates of the use of hematopoietic stem-cell transplantation in children with cancer in the United States
2005
Mitoxantrone
1996
In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells
1992 StandoutNobel
Requirement for CD44 in homing and engraftment of BCR-ABL–expressing leukemic stem cells
2006
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Considerations for Targeting Malignant Stem Cells in Leukemia
2004
Acute Myeloid Leukemia
2015 Standout
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA − Immunodeficient Patients
1995 Science
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
2006 StandoutNature
Rapid and efficient homing of human CD34+CD38−/lowCXCR4+stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2mnull mice
2001
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
2000 StandoutScience
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells
2007 Standout
Stored placental blood for unrelated bone marrow reconstitution
1993
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma
1995
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma
1993
Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma
1994
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
2005 Standout
Gene correction in hematopoietic progenitor cells by homologous recombination
2000 StandoutNobel
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
2010
Chimeric Antigen Receptor Therapy
2018 Standout
Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells
2001
Antibody therapy for acute myeloid leukaemia
2013
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
1999 Science
How I treat refractory and early relapsed acute myeloid leukemia
2015
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
Aberrant Eukaryotic Translation Initiation Factor 4E-Dependent mRNA Transport Impedes Hematopoietic Differentiation and Contributes to Leukemogenesis
2003
Stem cell concepts renew cancer research
2008
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
2001
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Cytokine dysregulation and acute graft-versus-host disease
1992
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
2000 StandoutScience
Characterization of acute lymphoblastic leukemia progenitor cells
2004
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length.
1986
State-of-the-Art Therapeutics: Hodgkin's Lymphoma
2005
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
2008 StandoutNobel
The Biology of Cancer Stem Cells
2007
Plasma elevation of stromal cell–derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells
2001 StandoutNobel
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Monoclonal Antibodies in Diagnosis and Therapy
1991 Science
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival
2005
Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
2013
Works of GL Phillips being referenced
Quantitation, Mobilization, and Clinical Use of Long-Term Culture-Initiating Cells in Blood Cell Autografts
1995
Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.
1991
Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer
1999
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells
2000
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation
1990
Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study [see comments]
1994
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults
1991
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study
1985
Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid- resistant acute graft-versus-host disease
1990
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy
1992
Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988
1991
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy
1992
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults
1991
Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study [see comments]
1994
Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected] [published erratum appears in Blood 1992 Jun 15;79(12):3397]
1991
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
1993